1006433-28-8 Usage
Explanation
The compound consists of 5 carbon atoms, 5 hydrogen atoms, 3 nitrogen atoms, 3 oxygen atoms, and 1 chlorine atom.
2. Reactive compound
Explanation
Due to the presence of a nitro group and a carbonyl chloride functional group, the compound is highly reactive and can participate in various chemical reactions.
3. Versatile use in organic synthesis and pharmaceutical research
Explanation
The compound's reactivity allows it to be used in a wide range of chemical reactions, making it a valuable tool in both organic synthesis and pharmaceutical research.
4. Carbonyl chloride derivative
Explanation
1-methyl-4-nitro-1H-pyrazole-3-carbonyl chloride is derived from 1-methyl-4-nitro-1H-pyrazole-3-carboxylic acid by replacing the carboxylic acid group with a carbonyl chloride functional group.
Explanation
The presence of these functional groups contributes to the compound's reactivity and allows it to participate in various chemical reactions, such as acylation and condensation reactions.
6. Intermediate in the synthesis of pharmaceuticals and agrochemicals
Explanation
Due to its reactivity and functional groups, 1-methyl-4-nitro-1H-pyrazole-3-carbonyl chloride is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, making it an important building block in synthetic organic chemistry.
Functional groups
Nitro group, carbonyl chloride
Check Digit Verification of cas no
The CAS Registry Mumber 1006433-28-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,6,4,3 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1006433-28:
(9*1)+(8*0)+(7*0)+(6*6)+(5*4)+(4*3)+(3*3)+(2*2)+(1*8)=98
98 % 10 = 8
So 1006433-28-8 is a valid CAS Registry Number.
1006433-28-8Relevant articles and documents
AROMATIC DERIVATIVES, PREPARATION METHODS, AND MEDICAL USES THEREOF
-
, (2020/09/19)
The present disclosure relates generally to aromatic derivatives that are inhibitors of FGFR4 and are useful in treating FGFR4-associated diseases or conditions. Compositions containing the compounds of the present disclosure are also provided.
4-SUBSTITUTED PYRROLO- AND PYRAZOLO-DIAZEPINES
-
Paragraph 0616; 0617, (2016/01/25)
BET protein-inhibitory, especially BRD2-, BRD3- and BRD4-inhibitory, 4-substituted pyrrolo- and pyrazolodiazepines of the general formula I are described, in which X, Y, n, m, p, R1, R2, R3, R4 and R5 are each as defined in the description, as are pharmaceutical compositions comprising the inventive compounds, and the prophylactic and therapeutic use thereof in the case of hyperproliferative disorders, especially in the case of neoplastic disorders. Also described is the use of the inventive compounds as BET protein inhibitors in benign hyperplasias, in atherosclerotic disorders, in sepsis, in autoimmune disorders, in vascular disorders, in viral infections, in neurodegenerative disorders, in inflammatory disorders and in male fertility control.
